Nasdaq
ROIV
Roivant Sciences Ltd.
- Health Care
- United Kingdom
- 1 day
- +1.5%
- 1 month
- −3.3%
- 1 year
- +201%
$35.12 · Mkt cap $25.4B
At the 6 Aug 2026 close
Nasdaq
Roivant Sciences Ltd.
$35.12 · Mkt cap $25.4B
At the 6 Aug 2026 close
Roivant Sciences Ltd. trades under the ticker ROIV on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $25.4B. The last closing price was $35.12, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +201%, and −3.3% over the past month. Returns are price returns and exclude dividends.
This page exists because ROIV is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.